Disposition of 200 shares by Kelsey Stephen Michael of Revolution Medicines at 4.09 subject to Rule 16b-3

RVMD Stock  USD 44.21  1.08  2.38%   
About 78 percent of Revolution Medicines' shareholders are selling. The analysis of the overall investor sentiment regarding Revolution Medicines suggests that quite a large number of traders are terrified. The current market sentiment, together with Revolution Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Revolution Medicines stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Revolution Medicines Officer: See Remarks. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 200 stock option (right to buy) at 4.09 of Revolution Medicines by Kelsey Stephen Michael on 24th of June 2024. This event was filed by Revolution Medicines with SEC on 2024-06-24. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Revolution Medicines' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Revolution Medicines' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Revolution Medicines Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Revolution Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Revolution Medicines Fundamental Analysis

We analyze Revolution Medicines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Revolution Medicines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Revolution Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Gross Profit

Gross Profit Comparative Analysis

Revolution Medicines is currently under evaluation in gross profit category among its peers. Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Revolution Medicines Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Revolution Medicines stock to make a market-neutral strategy. Peer analysis of Revolution Medicines could also be used in its relative valuation, which is a method of valuing Revolution Medicines by comparing valuation metrics with similar companies.

Peers

Revolution Medicines Related Equities

PASGPassage Bio   1.54   
0%
29.0%
AKROAkero Therapeutics   1.16   
0%
21.0%
RNAAvidity Biosciences   0.73   
13.0%
0%
PTGXProtagonist Therapeutics   1.39   
26.0%
0%
STOKStoke Therapeutics   1.60   
30.0%
0%
GLUEMonte Rosa   2.22   
41.0%
0%
BPMCBlueprint Medicines   2.42   
45.0%
0%
AGIOAgios Pharm   2.82   
53.0%
0%
NRIXNurix Therapeutics   4.11   
77.0%
0%
KYMRKymera Therapeutics   4.55   
86.0%
0%
BDTXBlack Diamond   4.78   
90.0%
0%
CCCCC4 Therapeutics   5.25   
99.0%
0%
SANASana Biotechnology   5.29   
100.0%
0%

Complementary Tools for Revolution Stock analysis

When running Revolution Medicines' price analysis, check to measure Revolution Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines is operating at the current time. Most of Revolution Medicines' value examination focuses on studying past and present price action to predict the probability of Revolution Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines' price. Additionally, you may evaluate how the addition of Revolution Medicines to your portfolios can decrease your overall portfolio volatility.
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals